Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Sustaining short-term gains for future progress
Autore:
Canas, F;
Indirizzi:
Hosp Psiquiatrico Madrid, Dept Psychiat, Madrid, Spain Hosp Psiquiatrico Madrid Madrid Spain rid, Dept Psychiat, Madrid, Spain
Titolo Testata:
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
, volume: 16, anno: 2001, supplemento:, 1
pagine: S9 - S13
SICI:
0268-1315(200101)16:<S9:SSGFFP>2.0.ZU;2-A
Fonte:
ISI
Lingua:
ENG
Soggetto:
SCHIZOPHRENIC-PATIENTS; ANTIPSYCHOTICS; PSYCHOSIS;
Keywords:
acute psychosis; antipsychotics; intramuscular formulation; ziprasidone;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
33
Recensione:
Indirizzi per estratti:
Indirizzo: Canas, F Hosp Psiquiatrico Madrid, Dept Psychiat, Madrid, Spain Hosp Psiquiatrico Madrid Madrid Spain Psychiat, Madrid, Spain
Citazione:
F. Canas, "Sustaining short-term gains for future progress", INT CLIN PS, 16, 2001, pp. S9-S13

Abstract

Management of patients with acute psychosis represents a considerable challenge for many reasons. As acute psychosis is considered to be a psychiatric emergency that requires immediate and effective intervention, pharmacotherapy with antipsychotic drugs is the mainstay of treatment. The key treatment goals are to calm the agitated, assaultive, violent or disruptive patient, to minimize the danger to self and others and to achieve a smooth transition from intramuscular to oral maintenance treatment with mimimal side-effects. In most circumstances intramuscular formulations of antipsychotic drugs are the optimal treatment choice. However, only the conventional antipsychotics are currently available as intramuscular formulations and unfavourable tolerability profiles reduce the benefit/risk ratio and mag make futuretransition to oral treatment problematic. An intramuscular formulation of an atypical antipsychotic medication would have significant advantages, notonly during the acute psychotic phase but also during transition to oral maintenance treatment by enabling an effective and well-tolerated changeoverfrom intramuscular to oral drug treatment. (C) 2001 Lippincott Williams & Wilkins.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/11/19 alle ore 02:40:15